Literature DB >> 16948952

Hepatobiliary cancers. Clinical practice guidelines in oncology.

Al B Benson1, Tanios Bekaii-Saab, Edgar Ben-Josef, Leslie Blumgart, Bryan M Clary, Steven A Curley, Rene Davila, Craig C Earle, William D Ensminger, John F Gibbs, Daniel Laheru, Alan N Langnas, Sean J Mulvihill, Albert A Nemcek, James A Posey, Elin R Sigurdson, Mika Sinanan, Jean-Nicolas Vauthey, Alan P Venook, Lawrence D Wagman, Timothy J Yeatman.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16948952     DOI： 10.6004/jnccn.2006.0064

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  8 in total

Review 1.  Current Status of Hepatic Arterial Infusion Chemotherapy.

Authors:  Shuntaro Obi; Shinpei Sato; Toshihiro Kawai
Journal:  Liver Cancer       Date:  2015-08-12       Impact factor: 11.740

2.  Implications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancer.

Authors:  T Tsirlis; F Ausania; S A White; J J French; B C Jaques; R M Charnley; D M Manas
Journal:  Ann R Coll Surg Engl       Date:  2015-03       Impact factor: 1.891

3.  Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.

Authors:  Xiao-Dong He; Jing-Jing Li; Wei Liu; Qiang Qu; Tao Hong; Xie-Qun Xu; Bing-Lu Li; Ying Wang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

4.  Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival.

Authors:  Tammy T Chang; Rajiv Sawhney; Alexander Monto; J Ben Davoren; Jacob G Kirkland; Lygia Stewart; Carlos U Corvera
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

5.  A critical analysis of the surgical management of early-stage gallbladder cancer in the United States.

Authors:  Eric H Jensen; Anasooya Abraham; Elizabeth B Habermann; Waddah B Al-Refaie; Selwyn M Vickers; Beth A Virnig; Todd M Tuttle
Journal:  J Gastrointest Surg       Date:  2008-12-13       Impact factor: 3.452

6.  Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.

Authors:  Manon Buijs; Diane K Reyes; Timothy M Pawlik; Amanda L Blackford; Riad Salem; Wells A Messersmith; Colin D Weekes; Mary Mulcahy; Ihab R Kamel; Jean-Francois H Geschwind
Journal:  Cancer       Date:  2012-11-06       Impact factor: 6.860

7.  Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial.

Authors:  Hao Li; Zheng-Yun Zhang; Zun-Qiang Zhou; Jiao Guan; Da-Nian Tong; Guang-Wen Zhou
Journal:  Oncotarget       Date:  2016-05-03

8.  Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization.

Authors:  Chao He; Xiaoyun Zhang; Chuan Li; Wei Peng; Tian-Fu Wen; Lv-Nan Yan; Jiayin Yang; Wusheng Lu
Journal:  Oncotarget       Date:  2017-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.